AurorA-TT is a venture capital and technology transfer intermediation firm based in Milan, Italy. The firm focuses on early-stage biotech and pharma companies based in Italy. The firm invests in pre-seed and seed projects to bridge the gap between basic research and industrial drug development with industrial discipline. The firm's portfolio is focused on the oncology, immunology, rare diseases, infectious diseases, cardiovascular diseases and CNS diseases.